Moreover, in AML, HDAC1/2/3 can be aberrantly recruited by AML1-ETO fusion protein to repress AML1 target genes, resulting in cellular transformation [28, 29], indicating their oncogenic roles. This evidence concerns the gene HDAC1 and acute myeloid leukemia.